Tango Therapeutics TNGX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's accumulated depreciation?
- Tango Therapeutics (TNGX) reported accumulated depreciation of $10.94M in Q1 2026.
- How has Tango Therapeutics's accumulated depreciation changed year-over-year?
- Tango Therapeutics's accumulated depreciation increased by 21.8% year-over-year, from $8.99M to $10.94M.
- What is the long-term trend for Tango Therapeutics's accumulated depreciation?
- Over 5 years (2020 to 2025), Tango Therapeutics's accumulated depreciation has grown at a 44.3% compound annual growth rate (CAGR), from $1.68M to $10.54M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.